These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 19502081)
21. Increased interleukin-6 level in Taiwanese schizophrenic patients. Lin CC; Chang CM; Chang PY; Huang TL Chang Gung Med J; 2011; 34(4):375-81. PubMed ID: 21880192 [TBL] [Abstract][Full Text] [Related]
22. Serum TNF-α, IL-10 and IL-2 in schizophrenic patients before and after treatment with risperidone and clozapine. Ajami A; Abedian F; Hamzeh Hosseini S; Akbarian E; Alizadeh-Navaei R; Taghipour M Iran J Immunol; 2014 Sep; 11(3):200-9. PubMed ID: 25265997 [TBL] [Abstract][Full Text] [Related]
23. Higher serum clozapine level is associated with increased antiphospholipid antibodies in schizophrenia patients. Shen H; Li R; Xiao H; Zhou Q; Cui Q; Chen J J Psychiatr Res; 2009 Mar; 43(6):615-9. PubMed ID: 18976782 [TBL] [Abstract][Full Text] [Related]
24. Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients. Raffa M; Mechri A; Othman LB; Fendri C; Gaha L; Kerkeni A Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1178-83. PubMed ID: 19576938 [TBL] [Abstract][Full Text] [Related]
25. Blind verification of elevated platelet autoantibodies in serum of schizophrenic patients--part II: adult subjects. Spivak B; Schechtman M; Schonherz-Pine Y; Blumensohn R; Mostovoy S; Amital D; Deckmann M; Weizman A; Shinitzky M Neuropsychobiology; 2009; 60(1):49-54. PubMed ID: 19729973 [TBL] [Abstract][Full Text] [Related]
26. [Correlations among mood disorder, serum interleukin-2 and interleukin-6 in patients with burning mouth syndrome]. Xia J; Lin M; Jin Z Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Oct; 21(5):377-8. PubMed ID: 14650995 [TBL] [Abstract][Full Text] [Related]
27. Changes in interleukin-1 beta and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients. Barak V; Barak Y; Levine J; Nisman B; Roisman I J Basic Clin Physiol Pharmacol; 1995; 6(1):61-9. PubMed ID: 8562579 [TBL] [Abstract][Full Text] [Related]
28. [Disorders of interleukin 2 biosynthesis by peripheral blood lymphocytes in patients with schizophrenia]. Sekirina TP; Voronkova TL; Tsutsu'lkovskaia MIa; Abramova LI Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(5):95-7. PubMed ID: 2789461 [TBL] [Abstract][Full Text] [Related]
30. [Validation of the Temporal Experience of Pleasure Scale (TEPS) in a French-speaking environment]. Favrod J; Ernst F; Giuliani F; Bonsack C Encephale; 2009 Jun; 35(3):241-8. PubMed ID: 19540410 [TBL] [Abstract][Full Text] [Related]
31. Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics. Zhang XY; Zhou DF; Qi LY; Chen S; Cao LY; Chen DC; Xiu MH; Wang F; Wu GY; Lu L; Kosten TA; Kosten TR Psychopharmacology (Berl); 2009 May; 204(1):177-84. PubMed ID: 19139851 [TBL] [Abstract][Full Text] [Related]
32. Increased interleukin-2 serum levels were associated with psychopathological symptoms and cognitive deficits in treatment-resistant schizophrenia. Tan Y; Li Y; Tan S; Wang Z; Yang FD; Cao B; Zunta-Soares GB; Soares JC; Zhang XY Schizophr Res; 2015 Dec; 169(1-3):16-21. PubMed ID: 26549630 [TBL] [Abstract][Full Text] [Related]
33. Oxidative/nitrative modifications of plasma proteins and thiols from patients with schizophrenia. Dietrich-Muszalska A; Olas B; Głowacki R; Bald E Neuropsychobiology; 2009; 59(1):1-7. PubMed ID: 19221441 [TBL] [Abstract][Full Text] [Related]
34. Association of blood levels of C-reactive protein with clinical phenotypes in Arab schizophrenic patients. Akanji AO; Ohaeri JU; Al-Shammri S; Fatania HR Psychiatry Res; 2009 Aug; 169(1):56-61. PubMed ID: 19619902 [TBL] [Abstract][Full Text] [Related]
35. Elevated interleukin-18 serum levels in chronic schizophrenia: Association with psychopathology. Xiu MH; Chen DC; Wang D; Zhang K; Dong A; Tang W; Zhang F; Liu LJ; Liu JH; Liu HB; Yang FD; Kosten TR; Zhang XY J Psychiatr Res; 2012 Aug; 46(8):1093-8. PubMed ID: 22647522 [TBL] [Abstract][Full Text] [Related]
36. Serum nitric oxide metabolite levels and the effect of antipsychotic therapy in schizophrenia. Taneli F; Pirildar S; Akdeniz F; Uyanik BS; Ari Z Arch Med Res; 2004; 35(5):401-5. PubMed ID: 15610909 [TBL] [Abstract][Full Text] [Related]
37. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. Maes M; Bosmans E; Calabrese J; Smith R; Meltzer HY J Psychiatr Res; 1995; 29(2):141-52. PubMed ID: 7666381 [TBL] [Abstract][Full Text] [Related]
38. Increase systemic levels of IL-23 as a possible constitutive marker in schizophrenia. Borovcanin M; Jovanovic I; Dejanovic SD; Radosavljevic G; Arsenijevic N; Lukic ML Psychoneuroendocrinology; 2015 Jun; 56():143-7. PubMed ID: 25827958 [TBL] [Abstract][Full Text] [Related]
39. Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Ganguli R; Yang Z; Shurin G; Chengappa KN; Brar JS; Gubbi AV; Rabin BS Psychiatry Res; 1994 Jan; 51(1):1-10. PubMed ID: 7910974 [TBL] [Abstract][Full Text] [Related]
40. [Schizophrenia and immunity]. Galinowski A; Levy-Soussan P; Lôo H Ann Med Psychol (Paris); 1992; 150(2-3):138-42. PubMed ID: 1364190 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]